$0.96
+0.02 (+1.93%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-28.61%
1Y
-30.68%
YTD
-30.68%
Open$0.95
Previous Close$0.94
Day High$0.97
Day Low$0.94
52W High$3.20
52W Low$0.81
Volume—
Avg Volume6.98M
Market Cap254.19M
P/E Ratio—
EPS$-0.11
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$1.26
Below
RSI (14)
38.1
Neutral
Analyst Ratings
Strong Buy
11 analysts
Price Target
+3,814.9% upside
Current
$0.96
$0.96
Target
$37.45
$37.45
$22.27
$37.45 avg
$46.32
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 254.30M | 273.09M | 65.59M |
| Net Income | -5,758,788 | -5,565,838 | -3,878,355 |
| Profit Margin | -2.3% | -2.2% | -5.9% |
| EBITDA | 25.31M | 25.82M | -4,128,349 |
| Free Cash Flow | — | — | -1,979,346 |
| Rev Growth | -6.9% | -6.9% | +11.6% |
| Debt/Equity | 5.94 | 5.94 | 0.17 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |